Vice President, Discovery and Preclinical Development at Avid Radiopharmaceuticals @ Eli Lilly and Company
Senior Director, Chemistry and Pharmaceutical Development @ Chlorion Pharma
Director to Senior Director, Medicinal Chemistry, CMC and Preclinical Development @ Gemin X Pharmaceuticals
Group Leader to Associate Director, Medicinal Chemistry @ BioChem Pharma Inc./Shire Pharmaceuticals
Giorgio Attardo's Education
McGill University
Ph.D. (Medicinal Chemistry and Organic Synthesis)
Armand Frappier Research Institute from the Pasteur International Network
Postdoctoral research (Antineoplastic and antiviral MedChem research)
1989 - 1990
Concordia University
Master of Science - MS (Mass Spectrometry)
Concordia University
Bachelor of Science - BS (Honours Chemistry)
Giorgio Attardo's Skills
Small molecule drug discovery & development
Medicinal Chemistry
DMPK
CMC
Pharmaceutical Development
In vitro & in vivo pharmacology
CNS
ONCOLOGY
Patents
Scientific due diligence
Giorgio Attardo's Summary
Giorgio Attardo, based in Boston, MA, US, is currently a Senior Vice President, CMC and Preclinical Drug Development at Karuna Therapeutics, bringing experience from previous roles at Karuna Therapeutics, Eli Lilly and Company, Chlorion Pharma and Gemin X Pharmaceuticals. Giorgio Attardo holds a Ph.D. in Medicinal Chemistry and Organic Synthesis @ McGill University. With a robust skill set that includes Small molecule drug discovery & development, Medicinal Chemistry, DMPK, CMC, Pharmaceutical Development and more, Giorgio Attardo contributes valuable insights to the industry. Giorgio Attardo has 2 emails on RocketReach.